Department of Women's and Children's Health, Division of Obstetrics and Gynecology, Karolinska Institutet, Stockholm, Sweden.
Department of Public Health, Women's Health Research Unit, University of Cape Town, Cape Town, South Africa.
BJOG. 2019 Aug;126(9):1094-1102. doi: 10.1111/1471-0528.15684. Epub 2019 Apr 25.
Telemedicine is increasingly being used to access abortion services.
To assess the success rate, safety, and acceptability for women and providers of medical abortion using telemedicine.
We searched PubMed, EMBASE, ClinicalTrials.gov, and Web of Science up until 10 November 2017.
We selected studies where telemedicine was used for comprehensive medical abortion services, i.e. assessment/counselling, treatment, and follow up, reporting on success rate (continuing pregnancy, complete abortion, and surgical evacuation), safety (rate of blood transfusion and hospitalisation) or acceptability (satisfaction, dissatisfaction, and recommendation of the service).
Quantitative outcomes were summarised as a range of median rates. Qualitative data were summarised in a narrative synthesis.
Rates relevant to success rate, safety, and acceptability outcomes for women ≤10 weeks' gestation (GW) ranged from 0 to 1.9% for continuing pregnancy, 93.8 to 96.4% for complete abortion, 0.9 to 19.3% for surgical evacuation, 0 to 0.7% for blood transfusion, 0.07 to 2.8% for hospitalisation, 64 to 100% for satisfaction, 0.2 to 2.3% for dissatisfaction, and 90 to 98% for recommendation of the service. Rates in studies also including women >10 GW ranged from 1.3 to 2.3% for continuing pregnancy, 8.5 to 20.9% for surgical evacuation, and 90 to 100% for satisfaction. Qualitative studies on acceptability showed no negative impacts for women or providers.
Based on a synthesis of mainly self-reported data, medical abortion through telemedicine seems to be highly acceptable to women and providers, success rate and safety outcomes are similar to those reported in literature for in-person abortion care, and surgical evacuation rates are higher.
A systematic review of medical abortion through telemedicine shows outcome rates similar to in-person care.
远程医疗越来越多地被用于获取堕胎服务。
评估使用远程医疗进行药物流产的成功率、安全性和可接受性,为妇女和提供者。
我们搜索了 PubMed、EMBASE、ClinicalTrials.gov 和 Web of Science,截至 2017 年 11 月 10 日。
我们选择了使用远程医疗提供全面药物流产服务的研究,即评估/咨询、治疗和随访,报告成功率(持续妊娠、完全流产和手术排空)、安全性(输血和住院率)或可接受性(满意度、不满度和对服务的推荐)。
定量结果总结为一系列中位数率。定性数据以叙述性综合形式总结。
对于≤10 孕周(GW)的女性,与成功率、安全性和可接受性相关的结果率范围为 0 至 1.9%的持续妊娠、93.8 至 96.4%的完全流产、0.9 至 19.3%的手术排空、0 至 0.7%的输血、0.07 至 2.8%的住院、64 至 100%的满意度、0.2 至 2.3%的不满度和 90 至 98%的服务推荐率。包括>10 GW 女性的研究中的比率范围为 1.3 至 2.3%的持续妊娠、8.5 至 20.9%的手术排空和 90 至 100%的满意度。关于可接受性的定性研究表明,妇女和提供者没有受到负面影响。
基于主要自我报告数据的综合分析,远程医疗进行药物流产对妇女和提供者来说似乎是高度可接受的,成功率和安全性结果与文献中报道的面对面堕胎护理相似,手术排空率较高。
对远程医疗进行药物流产的系统评价显示,其结果率与面对面护理相似。